FMR »

Inhibikase Therapeutics shares owned by FMR

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by FMR from 13F filings

Historical chart of FMR investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by FMR

Quarter filed Position value Share count Share price at filing
2025-09-30 $171k 106k 1.62
2025-06-30 $281k 144k 1.95

More positions owned by FMR

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Netflix (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Ge Aerospace Com New (GE)
Wells Fargo & Company (WFC)

View all positions for FMR

Top funds holding Inhibikase Therapeutics

Sands Capital Ventures
Soleus Capital Management
Fairmount Funds Management
Perceptive Advisors
Commodore Capital
ADAR1 Capital Management
Vanguard Group
BlackRock
Blackstone Group
Nantahala Capital Management
Geode Capital Management
Stonepine Capital Management
State Street Corporation
Northern Trust
William Blair $ Company

View all funds holding Inhibikase Therapeutics